{"id":"https://genegraph.clinicalgenome.org/r/dd441509-6f10-43c4-a114-7a45332413d4v1.0","type":"EvidenceStrengthAssertion","dc:description":"The *TBC1D8B* gene is located on chromosome X at q22.3 and encodes the protein Tre2-Bub2-Cdc16 (TBC)1 domain family member 8B, which is a GTPase-activating protein for specific Rab GTPases, such as RAB11 that regulate vesicular trafficking of nephrin. \n\n*TBC1D8B* was first reported in relation to X-linked early-onset steroid-resistant nephrotic syndrome in 2019 (Dorval et al., PMID: 30661770). The preferred disease name suggested for this disorder is ‘Nephrotic syndrome - *TBC1D8B*’. The mechanism of pathogenicity is known to be loss of function. Nephrotic syndrome - *TBC1D8B*  is characterized in existing literature by significant protein loss in the urine causing generalized edema with variable age of onset ranging from the first few months of life to 19 years. \n\nNine variants (frameshift, nonsense and missense) have been reported in 8 probands in 3 publications (PMIDs: 30661770, 31732614, 35970429) and are included in this curation. A total of 6.3/12 pts. for genetic evidence was reached, considering case-level data.\n\nThis gene-disease association is also supported by animal models, expression studies, in vitro functional assays, and rescue assays. TBC1D8B is expressed on mature human glomeruli (PMID 30661770), interacts with nephrin which is reduced in mutant TBC1D8B (PMID 31732614), and TBC1D8B mutation in vitro increased podocyte motility, increased cell adhesion, and impaired vesicular trafficking (PMID 30661770). TBC1D8B knockout in zebrafish caused glomerular proteinuria, podocyte foot process effacement and pericardial edema (PMID 30661770). Lastly, TBC1D8B knockdown in zebrafish could be rescued using wild-type mRNA (PMID 30661770). A total of 5/6 pts. for experimental evidence was reached.\n\nIn summary, there is moderate evidence supporting the relationship between TBC1D8B and X-linked Nephrotic syndrome.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/dd441509-6f10-43c4-a114-7a45332413d4","GCISnapshot":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c","calculatedEvidenceStrength":"Strong","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10068","date":"2024-01-09T08:51:56.574Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10068","date":"2023-04-25T02:30:00.000Z","role":"Approver"}],"curationReasonDescription":"Upon full curation with expert panel. Deemed more appropriate to round score of 11.3 to 11, consistent with moderate clinical validity classification","curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52407a66-f0a8-4b95-bbc2-9eb02cee44fc","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52407a66-f0a8-4b95-bbc2-9eb02cee44fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35970429","allele":{"id":"https://genegraph.clinicalgenome.org/r/087b01d0-f468-4733-a60f-a0f4c5312ab5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017752.3(TBC1D8B):c.1463_1467del (p.Ile488ArgfsTer16)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10483137"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4c3fe016-dd5c-43c1-bed8-e2103ddac604","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c3fe016-dd5c-43c1-bed8-e2103ddac604_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Murine Tbc1d8b cDNA constructs representing mutations from patients exhibit reduced binding affinity toward endogenous RAB11","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4c3fe016-dd5c-43c1-bed8-e2103ddac604_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31732614","allele":{"id":"https://genegraph.clinicalgenome.org/r/80cfb5e5-945e-409a-8de0-1434d1dddbd2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017752.3(TBC1D8B):c.190C>T (p.Arg64Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10482908"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/85bfcc1e-48a9-4f6b-89bc-f0bcc9d61283","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85bfcc1e-48a9-4f6b-89bc-f0bcc9d61283_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30661770","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4e80dfd-9a99-479e-b436-e25bc39d48b8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017752.3(TBC1D8B):c.872T>C (p.Phe291Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413824135"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ae480f9b-af51-4525-9e06-f02d554c166e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae480f9b-af51-4525-9e06-f02d554c166e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Murine Tbc1d8b cDNA constructs representing mutations from patients exhibit reduced binding affinity toward endogenous RAB11","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ae480f9b-af51-4525-9e06-f02d554c166e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31732614","allele":{"id":"https://genegraph.clinicalgenome.org/r/df88e66f-dc85-4d86-8ba0-30d663eb6bc1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017752.3(TBC1D8B):c.2338A>T (p.Thr780Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413814225"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d48aab8d-4a54-427c-be45-50ac0cd2b2d7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d48aab8d-4a54-427c-be45-50ac0cd2b2d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31732614","allele":{"id":"https://genegraph.clinicalgenome.org/r/ea1fed28-97e7-47f8-a1d7-a6f869e27fb9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XR_001755701.1(TBC1D8B):n.1481T>G (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413801152"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/99340abe-fee5-4d8d-8a65-adc1acdced01","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99340abe-fee5-4d8d-8a65-adc1acdced01_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Murine Tbc1d8b cDNA constructs representing mutations from patients exhibit reduced binding affinity toward endogenous RAB11","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/99340abe-fee5-4d8d-8a65-adc1acdced01_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31732614","allele":{"id":"https://genegraph.clinicalgenome.org/r/9184b4a7-7e1f-4354-897d-99321b966377","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017752.3(TBC1D8B):c.1383G>A (p.Trp461Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10483126"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4fab15cc-09e5-4439-82cc-3a2bca53afbc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fab15cc-09e5-4439-82cc-3a2bca53afbc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30661770","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c1bbfd5-91ae-4a62-9fb7-bfac22554db1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017752.3(TBC1D8B):c.738G>C (p.Gln246His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10483003"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/49b4108e-dadf-46e3-a0cb-ac6e78f026d5","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49b4108e-dadf-46e3-a0cb-ac6e78f026d5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31732614","allele":{"id":"https://genegraph.clinicalgenome.org/r/5f81444b-3c63-4893-8754-2871ba7aec3d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017752.3(TBC1D8B):c.1030C>T (p.Arg344Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10483044"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d0c03b2-e35d-417e-aeb8-8615c4e9d81c_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 3 affected individuals in X-linked condition","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30661770","rdfs:label":"A","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/7d0c03b2-e35d-417e-aeb8-8615c4e9d81c","type":"Family","rdfs:label":"A","member":{"id":"https://genegraph.clinicalgenome.org/r/287e85a3-8caa-4cb4-b40e-305a5d3a715a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30661770","rdfs:label":"II-1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9c1bbfd5-91ae-4a62-9fb7-bfac22554db1"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4fab15cc-09e5-4439-82cc-3a2bca53afbc_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Congenital or early-onset nephrotic syndrome ","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":0,"proband":{"id":"https://genegraph.clinicalgenome.org/r/287e85a3-8caa-4cb4-b40e-305a5d3a715a"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6.3},{"id":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f7332cf-ca89-4366-ac24-4f76e3ca7eed","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36ebaec3-4a58-419e-9c8c-ee471bb229db","type":"Finding","dc:description":"Proteinuria and significant podocyte foot process effacement on electron microscopy is a hallmark of nephrotic syndrome in humans. Pericardial edema is a manifestation of nephrotic syndrome","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30661770","rdfs:label":"Zebrafish knock-out (KO) of tbc1d8b ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5f3f33a3-1bf5-426f-a7d9-3ae0561913e2","type":"EvidenceLine","dc:description":"Only rescue knockdown model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d540e49c-e6ed-4512-b5c3-d0b9b1aa4fbf","type":"Finding","dc:description":"Decreased edema with human short isoform of wild-type or mutant mRNAs. However, only very partial rescue with mutant mRNAs, suggesting mutations are damaging but likely retain modest protein residual activity\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30661770","rdfs:label":"Morpholino knockdown rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4637283-dfb5-46af-b4c3-c2da22e790a7","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dfb3537-8a0a-46c0-b2c6-2f382bfc07eb","type":"FunctionalAlteration","dc:description":"Impaired vesicular trafficking on transferrin endocytosis and recycling assays in affected patient fibroblasts and podocytes harbouring p.Phe291Ser \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30661770","rdfs:label":"Podocytes from individual with p.Phe291Ser mutation"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6eac03e8-0b58-427e-b174-8ada5fad1f1c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb6a5f13-3bd4-492c-a0f2-77b870659ef8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2828f316-ce9e-40ee-85fa-3d2de511b5d8","type":"Finding","dc:description":"Murine Tbc1d8b cDNA constructs that reflect the mutations from patients with nephrotic syndrome exhibit reduced binding affinity toward nephrin","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31732614","rdfs:label":"Coimmunoprecipitation assay","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8c4d0fc6-3bda-4da2-97ff-e56063633c61","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f9c0843-0eac-4339-8d2d-a7cd3ddb7eb6","type":"Finding","dc:description":"TBC1D8B both in glomerular podocytes and tubules at early stages (25 weeks, fetal kidney) and in mature kidney (7 year old). In glomeruli, TBC1D8B colocalized with synaptopodin\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30661770","rdfs:label":"TBC1D8B staining in human kidney ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Moderate","sequence":7457,"specifiedBy":"GeneValidityCriteria9","strengthScore":11.3,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ShOMwoNUQWE","type":"GeneValidityProposition","disease":"obo:MONDO_0026726","gene":"hgnc:24715","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_6eac03e8-0b58-427e-b174-8ada5fad1f1c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}